Please, set Additional Menu

Who We Are

About Us

Abaxys Therapeutics is a biopharmaceutical company aiming to accelerate the development of highly innovative programs with strong therapeutic potential

Our Vision

ABAXYS aims to become a key player and first-choice partner in the area of human CNS diseases contributing to the development of highly innovative therapeutic solutions for neurological and neurodegenerative diseases, including neuro-orphan diseases.

Our Mission

Build-up a ‘First- and Best -in-Class’ Innovative Portfolio of Medicines for Human Neurodegenerative Diseases.

ABAXYS aims to reduce significantly the time-to-clinics of preclinical programs and contribute to develop efficacious disease modifying therapies for brain neurodegenerative diseases

Our neuroscience discovery efforts identified new therapeutic strategies aiming disease-modifying interventions by small chemical molecules and gene therapies

Own technological platforms on Big-data mining, high-resolution bio-imaging and disease-modeling strengthen the pre-clinical pipeline

Abaxys Therapeutics is advancing new medicinal drugs for the treatment of human neurodegenerative diseases such as Parkinson’s and Alzheimer’s disease

The company is at the center of a strong strategic partnership network with a constellation of top academic institutions and small biotechs in the area of neurosciences

Our Key Approach

Our strategy is based on a business model which uses the local and European top R&D ecosystem to deliver disruptive Preclinical packages contributing to High Value Pharma Therapeutic programs

Hit Identification

With our Data Mining approach, we are able to efficiently identify new Hits.

Lead Optimization

With our Big Data and Simulation approach, we are able to accelerate the Preclinical process (from 3-5 years in only 6 months) by replacing lab, in-vitro, in-vivo experience with in-sillico validation.

Animal Modeling

With our Bio-imaging approach, we do not have to kill the Animal Model to see the impact of a drug. Thus we are able to follow the evolution of the disease, see the impact of a molecule and better predict the efficacy in human.

Our Team

ABAXYS team has a long experience in pharmaceutical research in neurosciences and in company creation in the area of biotechnology. We have a strong commitment to capitalize the value of our team and our partners in order to deliver successful medicines to patients.

Our Team

  • /
    Javier Garcia-Ladona
    Founder & CEO
  • /
    Guillaume de Viron
  • /
    Valentin Tonnel
    Business Developer
  • /
    Work with us
    Apply here

Our Partners